Ginkgo Bioworks Holdings (DNA)

NYSE


Symbol		Exchange		Currency
DNA	·	NYSE	·	USD	Real-time
9L40	·	TradeGate	·	EUR	Delayed

Currency in USD

DNA Pro Research

9.000

-0.290(-3.12%)

Closed·17/02

After Hours

9.060+0.060(+0.67%)

·17/02

Fair Value

Unlock Value

Day's Range

8.740

9.360

52 wk Range

5.000

17.580

DNA Income Statement

Assess the Ginkgo Bioworks income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the DNA net worth.

Period Ending:

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Total Revenues

aa.aa

227.04

Total Revenues Growth

aa.aa

-9.71%

Cost Of Revenues

aa.aa

44.55

Gross Profit

aa.aa

182.5

Gross Profit Growth

aa.aa

-7.57%

Gross Profit Margin %

aa.aa

80.38%

Other Operating Expenses, Total

aa.aa

661.21

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-29%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	424.06
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	237.15
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-

Operating Income

aa.aa

-478.72

Operating Income Growth

aa.aa

+34.76%

EBIT Margin %

aa.aa

-210.85%

Net Interest Expenses

aa.aa

38.52

Net Interest Expenses Growth

aa.aa

-32.57%

Interest Expense, Total

aa.aa

-0.09

Interest And Investment Income

aa.aa

38.61

Other Non Operating Expenses, Total

aa.aa

9.57

EBT, Excl. Unusual Items

aa.aa

-430.63

Gain (Loss) On Sale Of Assets

aa.aa

-7.01

Other Unusual Items, Total

aa.aa

-9.01

EBT, Incl. Unusual Items

aa.aa

-547.51

EBT, Incl. Unusual Items Growth

aa.aa

+38.68%

EBT, Incl. Unusual Items Margin

aa.aa

-241.15%

Income Tax Expense

aa.aa

-0.48

Net Income to Company

aa.aa

-547.03

Minority Interest

aa.aa

Net Income

aa.aa

-547.03

Net Income Growth

aa.aa

+38.73%

Net Income Margin %

aa.aa

-240.94%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-547.03

Basic EPS - Continuing Operations

aa.aa

-10.54

Basic EPS - Continuing Operations Growth

aa.aa

+42.61%

Diluted EPS - Continuing Operations

aa.aa

-10.54

Diluted EPS - Continuing Operations Growth

aa.aa

+42.62%

Basic Weighted Average Shares Outstanding

aa.aa

51.89

Diluted Weighted Average Shares Outstanding

aa.aa

51.89

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-415.7

EBITDA Growth

aa.aa

+37.33%

EBITDA Margin %

aa.aa

-183.09%

EBIT

aa.aa

-478.72

* In Millions of USD (except for per share items)

FAQ

What was Ginkgo Bioworks’s revenue at year end?

At the end of the last reported fiscal year, Ginkgo Bioworks (DNA) recorded total revenue of 227.043 million USD.

How much revenue did Ginkgo Bioworks report in the most recent quarter?

In its most recent quarterly earnings report, Ginkgo Bioworks posted revenue of 38.837 million USD.

What was Ginkgo Bioworks’s net income for the year?

For the full year, Ginkgo Bioworks reported net income of -547.029 million USD.

How much net income did Ginkgo Bioworks post in the last quarter?

In the most recent quarter, Ginkgo Bioworks (DNA) posted net income of -80.755 million USD.

What was Ginkgo Bioworks’s gross profit for the year?

Gross profit for the year was reported at 182.495 million USD.

How much gross profit did Ginkgo Bioworks generate last quarter?

Ginkgo Bioworks recorded gross profit of 26.035 million USD in its latest quarterly report.

What was Ginkgo Bioworks’s annual operating income?

For the full year, Ginkgo Bioworks (DNA) reported operating income of -478.717 million USD.

What was Ginkgo Bioworks’s operating income last quarter?

Quarterly operating income was -88.272 million USD.

What was Ginkgo Bioworks’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -88.104 million USD.

What was the quarter-over-quarter change in EBITDA for Ginkgo Bioworks?

EBITDA changed by -91.223% million USD compared to the last quarter.

What is Ginkgo Bioworks’s most recent gross profit margin?

The latest reported gross profit margin for Ginkgo Bioworks (DNA) is 67.037% million USD.

What is Ginkgo Bioworks’s most recent net income margin?

Net income margin based on recent financials is -207.933% million USD.

What is Ginkgo Bioworks’s most recent EBIT margin?

Ginkgo Bioworks reported an EBIT margin of -227.288% based on current figures.

How did Ginkgo Bioworks’s revenue change compared to the previous quarter?

Revenue changed by -21.706% compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Ginkgo Bioworks?

In the latest quarter 2026, gross profit changed by -25.148% from the previous quarter.

S&P/TSX

32,896.55

-177.16

-0.54%

S&P/TSX 60

1,909.29

-7.86

-0.41%

US 30

49,793.30

+260.1

+0.53%

US 500

6,884.50

+41.3

+0.60%

S&P 500 VIX

19.41

-0.88

-4.34%

DAX

25,206.94

+201.60

+0.81%

Dollar Index

97.195

+0.135

+0.14%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	70.21	-4.22%	24.22M
Canadian Natural	55.38	-0.02%	8.85M
Barrick Mining	63.64	-2.57%	8.40M
Suncor Energy	75.20	-1.38%	6.87M
TC Energy	84.91	-1.86%	5.84M
RBC	230.99	0.00%	4.65M
Toronto Dominion Bank	130.40	+0.36%	3.79M

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	+500.00%	1.32K
New Leaf Ventures	0.05	+400.00%	666.82K
HFX Holding	0.0500	+150.00%	200.00K
Irwin Naturals	0.30	+150.00%	3.24K
Wedgemount Resources	0.05	+150.00%	164.66K
Green Panda Capital	0.12	+140.00%	321.66K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K

Name	Last	Chg. %	Vol.
Metamaterial	0.25	-92.86%	0.00
Planet Based Foods Global	0.01	-81.82%	35.00K
TripSitter Clinic	0.07	-56.67%	155.01K
Gemina Laboratories	0.03	-50.00%	18.25K
James Bay Resources Ltd	0.005	-50.00%	2.33K
Clean Energy Transition	0.0250	-50.00%	16.14K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
Constellation Software	2,258.18	-4.18%	123.53K
TELUS	18.62	+1.47%	7.30M
Celestica Inc.	390.87	+2.40%	687.00K
Air Canada	20.53	+1.38%	2.51M
Thomson Reuters	113.48	-4.20%	950.90K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaa Aaaa A	92.47	+62.27%	150.05
Aaaaaa Aaaaaa Aaa	100.04	+49.18%	149.24
Aaa Aaa Aaaa Aa	8.17	+43.54%	11.73
Aaaaaa A	2,258.18	+42.16%	3,210.23
Aaaaaa A A	22.61	+40.23%	31.71
A Aaaaaaaaaaa	27.82	+37.07%	38.13
Aaa Aa	262.06	+35.46%	354.99

Name	Last	Upside	Fair Value
Aaaa Aaaa A	92.47	+62.27%	150.05
Aaaaaa Aaaaaa Aaa	100.04	+49.18%	149.24
Aaa Aaa Aaaa Aa	8.17	+43.54%	11.73
Aaaaaa A	2,258.18	+42.16%	3,210.23
Aaaaaa A A	22.61	+40.23%	31.71
A Aaaaaaaaaaa	27.82	+37.07%	38.13
Aaa Aa	262.06	+35.46%	354.99

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Ginkgo Bioworks Holdings (DNA)

DNA Income Statement

FAQ

What was Ginkgo Bioworks’s revenue at year end?

How much revenue did Ginkgo Bioworks report in the most recent quarter?

What was Ginkgo Bioworks’s net income for the year?

How much net income did Ginkgo Bioworks post in the last quarter?

What was Ginkgo Bioworks’s gross profit for the year?

How much gross profit did Ginkgo Bioworks generate last quarter?

What was Ginkgo Bioworks’s annual operating income?

What was Ginkgo Bioworks’s operating income last quarter?

What was Ginkgo Bioworks’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Ginkgo Bioworks?

What is Ginkgo Bioworks’s most recent gross profit margin?

What is Ginkgo Bioworks’s most recent net income margin?

What is Ginkgo Bioworks’s most recent EBIT margin?

How did Ginkgo Bioworks’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Ginkgo Bioworks?

Trending Stocks